Stock & Company Details
Cognition Therapeutics Inc $CGTX
Price:
46,691,331
89M
$82M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Services
CGTX technical indicators
Latest Cognition Therapeutics Inc (CGTX) technical indicators as of 2026-07-27: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
40.56 7.9%
MACD:
-0.07 2.7%
SMA 50:
$1.16 0.4%
SMA 200:
$1.29 0.3%
EMA 20:
$1.03 0.8%
Bollinger Bands:
1.18 / 0.88
Stochastic:
13.31 18.4%
ADX 14:
21.73 1.9%
ATR 14:
0.10 3.0%
CCI 20:
-86.96 11.8%
OBV:
570.04M 0.1%
ROC 12:
-12.84% 8.4%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Finance Bot
Ask your questions
Start by typing a question below.
